Abstract
Background
Much of the knowledge on the use of potentially inappropriate medications (PIM) in older adults is derived from cross-sectional studies, with little known about the risk factors over time.
Aim
Longitudinal analysis was applied to estimate the occurrence and risk factors of PIM use among older adults in a 10-year follow-up.
Method
Longitudinal study with 418 older adult residents of a capital city of Central-West Brazil. The PIM were classified according to the Beers criteria 2019. The usage rate was calculated at baseline (2008) and at the 10-year follow-up moment (2018). Analysis of predictors (sociodemographic, self-rated health, hospitalization, number of comorbidities, polypharmacy, diabetes, hypertension, hypercholesterolemia and nutritional status) was performed using Generalized Estimating Equation (GEE) models.
Results
Mean age at baseline was 70.6 years (SD 7.1) and 76% were women; 221 older adults took part in the follow up. The rate of PIM use was 50.4% at baseline and 57.5% at the 10-year follow-up. Multiple analysis showed that PIM use in the cohort was statistically higher in the older adults with a history of hospitalization (RRadj 1.20; 95% CI 1.01–1.40), with three or more diseases (RRadj 1.41; 95% CI 1.14–1.74), with polypharmacy (RRadj 1.81; 95% CI 1.47–2.24) and with diabetes mellitus (RRadj 1.24; 95% CI 1.05–1.47).
Conclusion
A high level of potentially inappropriate medication use was observed, reaching 50% of the older adults, with a 7% increase in the prevalence over the 10-year follow-up period. Hospitalization, multimorbidities, polypharmacy and diabetes mellitus were associated with the use of these medications. Interventions for surveillance of the deprescribing process need to be encouraged to avoid potential harm caused by the use of medications.
Similar content being viewed by others
References
Alyazeedi A, Algendy AF, Sharabash M, et al. Prevalence, determinants and associated risk of potentially inappropriate prescribing for older adults in Qatar: a National Retrospective Study. Clin Interv Aging. 2019;14:1889–99. https://doi.org/10.2147/CIA.S222532.
Roux B, Sirois C, Simard M, et al. One-year persistence of potentially inappropriate medication use in older adults: a population-based study. Br J Clin Pharmacol. 2020;86(6):1062–80. https://doi.org/10.1111/bcp.14214.
American Geriatrics Society. American Geriatrics Society 2019 updated AGS beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94. https://doi.org/10.1111/jgs.15767.
Clark CM, Shaver AL, Aurelio LA, et al. Potentially inappropriate medications are associated with increased healthcare utilization and costs. J Am Geriatr Soc. 2020;68(11):2542–50. https://doi.org/10.1111/jgs.16743.
Santos TRA, Lima DM, Nakatani AYK, et al. Medicine use by the elderly in Goiania, Midwestern Brazil. Rev Saude Publica. 2013;47(1):94–103. https://doi.org/10.1590/S0034-89102013000100013.
Cassoni TCJ, Corona LP, Romano-Lieber NS, et al. Use of potentially inappropriate medication by the elderly in São Paulo, Brazil: SABE Study. Cad Saude Publica. 2014;30(8):1708–20. https://doi.org/10.1590/0102-311X00055613.
Pagno AR, Gross CB, Gewehr DM, et al. Drug therapy, potential interactions and iatrogenesis as factors related to frailty in the elderly. Rev Bras Geriatr Gerontol. 2018;21(5):588–96. https://doi.org/10.1590/1981-22562018021.180085.
Morin L, Fastbom J, Laroche ML, et al. Potentially inappropriate drug use in older people: a nationwide comparison of different explicit criteria for population-based estimates. Br J Clin Pharmacol. 2015;80(2):315–24. https://doi.org/10.1111/bcp.12615.
Saboor M, Kamrani AA, Momtaz YA, et al. Prevalence and associated factors of potentially inappropriate medications among Iranian older adults. Med Glas (Zenica). 2019;16(1):121–7. https://doi.org/10.17392/989-19.
Saka SA, Oosthuizen F, Nlooto M. Potential inappropriate prescribing and associated factors among older persons in Nigeria and South Africa. Int J Clin Pharm. 2019;41(1):207–14. https://doi.org/10.1007/s11096-018-0770-1.
Fujie K, Kamei R, Araki R, et al. Prescription of potentially inappropriate medications in elderly outpatients: a survey using 2015 Japanese Guidelines. Int J Clin Pharm. 2020;42(2):579–87. https://doi.org/10.1007/s11096-020-00967-9.
Thorell K, Midlöv P, Fastbom J, et al. Importance of potentially inappropriate medications, number of chronic conditions and medications for the risk of hospitalization in elderly in Sweden: a case-control study. BMJ Open. 2019;9(9):e029477. https://doi.org/10.1136/bmjopen-2019-029477.
Wang TC, Ku PJ, Lu HL, et al. Association between potentially inappropriate medication use and chronic diseases in the elderly. Int J Environ Res Public Health. 2019;16(12):2189. https://doi.org/10.3390/ijerph16122189.
do Nascimento MM, Mambrini JV, Lima-Costa MF, et al. Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. Eur J Clin Pharmacol. 2017;73(5):615–21. https://doi.org/10.1007/s00228-017-2202-x.
Jungo KT, Streit S, Lauffenburger JC. Utilization and spending on potentially inappropriate medications by US older adults with multiple chronic conditions using multiple medications. Arch Gerontol Geriatr. 2020;93: 104326. https://doi.org/10.1016/j.archger.2020.104326.
De Araújo NC, Silveira EA, Godoi B, et al. Potentially inappropriate medications for the elderly: incidence and impact on mortality in a cohort ten-year follow-up. PLoS ONE. 2020;15(10): e0240104. https://doi.org/10.1371/journal.pone.0240104.
Weir DL, Lee TC, McDonald EG, et al. Both new and chronic potentially inappropriate medications continued at hospital discharge are associated with increased risk of adverse events. J Am Geriatr Soc. 2020;68(6):1184–92. https://doi.org/10.1111/jgs.16413.
Silveira EA, Dalastra L, Pagotto V. Polypharmacy, chronic diseases and nutritional markers in Community-dwelling older. Rev Bras Epidemiol. 2014. https://doi.org/10.1590/1809-4503201400040002.
Silveira EA, Ferreira CCC, Pagotto V, et al. Total and central obesity in elderly associated with a marker of undernutrition in early life-sitting height-to-stature ratio: a nutritional paradox. Am J Hum Biol. 2017;29(3):55. https://doi.org/10.1002/ajhb.22977.
Associação Brasileira de Empresas de Pesquisa - ABEP. Critério Brasil: Critério de Classificação Econômica Brasil –Base. 2018. http://www.abep.org/criterio-brasil.
Gnjidic D, Tinetti M, Allore HG. Assessing medication burden and polypharmacy: finding the perfect measure. Expert Rev Clin Pharmacol. 2017;10(4):345–7. https://doi.org/10.1080/17512433.2017.1301206.
Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1994;21(1):55–67.
Barroso WKS, Rodrigues CIS, Bortolotto LA, et al. Diretrizes Brasileiras de Hipertensão Arterial – 2020. Arq Bras Cardiol. 2021;116:516–658. https://doi.org/10.36660/abc.20201238.
Sociedade Brasileira de Diabetes. Diretrizes da Sociedade Brasileira de Diabetes 2019–2020. 2019. https://www.diabetes.org.br/profissionais/images/DIRETRIZES-COMPLETA-2019-2020.pdf. Accessed 15 July 2019.
Sheikh A, Dhingra-Kumar N, Kelley E, et al. The third global patient safety challenge: tackling medication-related harm. Bull World Health Organ. 2017;95(8):546–646. https://doi.org/10.2471/BLT.17.198002.
Komagamine J, Hagane K. Effect of total exemption from medical service co-payments on potentially inappropriate medication use among elderly ambulatory patients in a single center in Japan: a retrospective cross-sectional study. BMC Res Notes. 2018;11(1):199. https://doi.org/10.1186/s13104-018-3320-y.
Rodríguez-Pérez A, Santos-Ramos B, Alfaro-Lara ER. Deprescribing: guiding its definition. Farm Hosp. 2017;41(6):698–9. https://doi.org/10.7399/fh.10848.
Mangin D, Bahat G, Golomb BA, et al. International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging. 2018;35(7):575–658. https://doi.org/10.1007/s40266-018-0554-2.
Slater N, White S, Venables R, et al. Factors associated with polypharmacy in primary care: a cross-sectional analysis of data from the English Longitudinal Study of Ageing (ELSA). BMJ Open. 2018;8: e020270. https://doi.org/10.1136/bmjopen-2017-020270.
Lutz BH, Miranda VIA, Bertoldi AD. Potentially inappropriate medications among older adults in Pelotas, Southern Brazil. Rev Saúde Pública. 2017;22(51):52. https://doi.org/10.1590/S1518-8787.2017051006556.
Miranda GMD, Mendes ACG, da Silva ALA. O envelhecimento populacional brasileiro: desafios e consequências sociais atuais e futuras. Rev Bras Geriatr Gerontol. 2016;19(3):507–19. https://doi.org/10.1590/1809-98232016019.150140.
Nascimento MMG, Mambrini JVM, Lima-Costa MF, et al. Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. Eur J Clin Pharmacol. 2017;73(5):615–21. https://doi.org/10.1007/s00228-017-2202-x.
Awadi A, Hanna O. Potentially inappropriate medication use among geriatric patients in primary care setting: a cross-sectional study using the Beers, STOPP, FORTA and MAI criteria. PLoS ONE. 2019;14(6): e0218174. https://doi.org/10.1371/journal.pone.0218174.
Abdulah R, Insani WN, Destiani DP, et al. Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities. Ther Clin Risk Manag. 2018;14:1591–7. https://doi.org/10.2147/TCRM.S170475.
Porter B, Arthur A, Savva GM. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. BMJ Open. 2019;9: e026171. https://doi.org/10.1136/bmjopen-2018-026171.
Leelakanok N, Holcombe AL, Lund BC, et al. Association between polypharmacy and death: A systematic review and meta-analysis. J Am Pharm Assoc. 2017;57(6):729–38. https://doi.org/10.1016/j.japh.2017.06.002.
Ribeiro MR, Motta AA, Marcondes-Fonseca LA, et al. Increase of 10% in the rate of adverse drug reactions for each drug administered in hospitalized patients. Clinics (Sao Paulo). 2018;73: e185. https://doi.org/10.6061/clinics/2018/e185.
Silva MRR, Diniz LM, Santos JBR, et al. Drug utilization and factors associated with polypharmacy in individuals with diabetes mellitus in Minas Gerais, Brazil. Ciên Saude Colet. 2018;23(8):2565–74. https://doi.org/10.1590/1413-81232018238.10222016.
Vitoi NC, Fogal AS, Nascimento CM, et al. Prevalence and associated factors of diabetes in the elderly population in Viçosa, Minas Gerais, Brazil. Rev Bras Epidemiol. 2015;18(4):953–65. https://doi.org/10.1590/1980-5497201500040022.
Araujo MF, Freitas RW, Fragoso LV, et al. Oral antidiabetic drug therapy compliance among Brazilian public health system users. Texto Contexto Enferm. 2011;20:135–43. https://doi.org/10.1590/S0104-07072011000100016.
Moraes SA, da Freitas IC, Gimeno SG, et al. Prevalência de diabetes mellitus e identificação de fatores associados em adultos residentes em área urbana de Ribeirão Preto, São Paulo, Brasil: Projeto Obediarp. Cad Saúde Pública. 2010;26:929–41. https://doi.org/10.1590/S0102-311X2010000500015
Corralo VS, Binotto VM, Bohnen LC, et al. Polypharmacy and associated factors in elderly diabetic. Rev Salud Pública (Bogota). 2018;20(3):366–72. https://doi.org/10.15446/rsap.V20n3.50304.
Oktora MP, Alfian SD, Bos HJ, et al. Trends in polypharmacy and potentially inappropriate medication (PIM) in older and middle-aged people treated for diabetes. Br J Clin Pharmacol. 2020;87:2807–17. https://doi.org/10.1111/bcp.14685.
Gagnon ME, Sirois C, Simard M, et al. Potentially inappropriate medications in older individuals with diabetes: a population-based study in Quebec, Canada. Prim Care Diabetes. 2020;14(5):529–37. https://doi.org/10.1016/j.pcd.2020.03.003.
Nunes BP, Batista SRR, Bof FA, et al. Multimorbidade em indivíduos com 50 anos ou mais de idade: ELSI-Brasil. Rev Saude Publica. 2018;52(Suppl 2):10s. https://doi.org/10.11606/S1518-8787.2018052000637.
Heider D, Matschinger H, Meid AD, et al. Health service use, costs, and adverse events associated with potentially inappropriate medication in old age in Germany: retrospective matched cohort study. Drugs Aging. 2017;34(4):289–301. https://doi.org/10.1007/s40266-017-0441-2.
Neves SJF, Marques APO, Leal MCC, et al. Epidemiologia do uso de medicamentos entre idosos em área urbana do Nordeste do Brasil. Rev Saude Publica. 2013;47(4):1–10. https://doi.org/10.1590/S0034-8910.2013047003768.
Assis DL, Chagas VO, Valente M, et al. Polypharmacy and the use of inappropriate medications in institutionalized elderly: lessons still not learned. Geriatr Gerontol Aging. 2016;10:126–31. https://doi.org/10.5327/Z2447-211520161600020.
Viana SSC. O uso de medicamentos potencialmente inapropriados e a ocorrência de quedas e hospitalizações em idosos ambulatoriais após condição aguda: estudo de coorte retrospectivo [dissertação]. 2019:85. https://doi.org/10.11606/D.5.2019.tde-29102019-103540.
Funding
This study was supported by the National Council for Scientific and Technological Development of Brazil (CNPq), Grant no. 428635/2016–4, and in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
de Araújo, N.C., Silveira, E.A., Mota, B.G. et al. Risk factors for potentially inappropriate medication use in older adults: a cohort study. Int J Clin Pharm 44, 1132–1139 (2022). https://doi.org/10.1007/s11096-022-01433-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-022-01433-4